Format

Send to

Choose Destination
Mol Genet Metab. 2018 Sep;125(1-2):112-117. doi: 10.1016/j.ymgme.2018.07.007. Epub 2018 Jul 25.

Arginase overexpression in neurons and its effect on traumatic brain injury.

Author information

1
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA.
2
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
3
Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
4
Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
5
Department of Neurology, Weill Medical College of Cornell University, New York, NY, USA.
6
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: blee@bcm.edu.

Abstract

Arginine is a semi-essential amino acid which serves as a substrate for nitric oxide (NO) production by nitric oxide synthase (NOS) and a precursor for various metabolites including ornithine, creatine, polyamines, and agmatine. Arginase competes with nitric oxide synthase for substrate arginine to produce orthinine and urea. There is contradictory evidence in the literature on the role of nitric oxide in the pathophysiology of traumatic brain injury (TBI). These contradictory perspectives are likely due to different NOS isoforms - endothelial (eNOS), inducible (iNOS) and neuronal (nNOS) which are expressed in the central nervous system. Of these, the role of nNOS in acute injury remains less clear. This study aimed to employ a genetic approach by overexpressing arginase isoforms specifically in neurons using a Thy-1 promoter to manipulate cell autonomous NO production in the context of TBI. The hypothesis was that increased arginase would divert arginine from pathological NO production. We generated 2 mouse lines that overexpress arginase I (a cytoplasmic enzyme) or arginase II (a mitochondrial enzyme) in neurons of FVB mice. We found that two-weeks after induction of controlled cortical injury, overexpressing arginase I but not arginase II in neurons significantly reduced contusion size and contusion index compared to wild-type (WT) mice. This study establishes enhanced neuronal arginase levels as a strategy to affect the course of TBI and provides support for the potential role of neuronal NO production in this condition.

KEYWORDS:

Arginase; Arginine; Nitric oxide; Nitric oxide synthase; Traumatic brain injury

PMID:
30055993
PMCID:
PMC6175653
[Available on 2019-09-01]
DOI:
10.1016/j.ymgme.2018.07.007

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center